Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
202.40
Ask:
203.20
Spread: 0.80 (0.395%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Interim Management Statement

15 Jan 2009 07:00

RNS Number : 6665L
Ashmore Group PLC
15 January 2009
 



Ashmore Group plc

+0700 15 January 2009 

SECOND QUARTER ASSETS UNDER MANAGEMENT UPDATE

Ashmore Group plc ("Ashmore", the "Group"), a leading specialist emerging markets asset manager, announces today the following update on its assets under management ("AuM") in respect of the quarter ended 31 December 2008.

Assets under Management ("AuM") 

Actual

Estimated

Estimated

Theme

AuM

30 Sep 2008

(US$billion)

AuM

31 Dec 2008

(US$billion)

Movement vs 30 Sept 2008

 (%)

Dollar Debt 

19.2

14.7 

-23.4

Local Currency

7.4

5.4 

-27.0

Special Situations

5.0

4.4 

-12.0

Equity

0.3

0.1 

-66.7

Total

31.9

24.6 

-22.9

The quarter saw assets under management fall 22.9% to US$24.6 billion, reflecting a continuation of the turbulent markets seen in the first quarter. The constituents were US$4.2bn of performance, and US$3.1bn of net outflows. 

Following a particularly aggressive fall in October, all relevant indices ended the quarter down, some significantly, and our performance reflects this. There have been signs subsequently that markets are stabilising, with December 2008 providing the first overall positive performance month across all themes since May 2008.

The net outflows are relatively modest given the prolonged market uncertainty, and redemptions have largely reflected the liquidity needs of clients, rather than any adverse allocation to EM assets. 

There remain significant investment opportunities for our funds, where valuations have been driven lower by uncertainty surrounding the economic backdrop and reduced market liquidity, yet underlying business fundamentals are strong.

In line with the Group's stated policy, FX hedges are undertaken through forward contracts. FY08/09 management fees, reported in GBP, will not benefit from the current strength of the US Dollar, being fully hedged at current AuM levels at a rate of GBP1:1.95USD. Hedge contracts of US$100m are also in place to partially hedge FY09/10 management fees at a rate of GBP1:1.79USD. Under IFRS, the open hedge contracts are required to be marked-to-market as at 31 December 2008, whereas corresponding FX differences on management fees will only arise as those management fees are recognised in subsequent periods. This will create timing difference in the Interim Results and, to a lesser extent, the Final Results.

The Group remains focused on its stated strategy to deliver long term investment outperformance; generate and diversify net management fee income through the attraction of net subscriptions across investment themes; and develop the Ashmore brand and business model. The balance sheet remains strong, with cash balances of £300m, placing the Group in an excellent position to deliver on this strategy.

Ashmore will announce its interim results in respect of the six months ended 31 December 2008 at 0700 hours on 24 February 2009.

For further information, please contact:

Ashmore Group plc +44 (0)20 3077 6000

Graeme Dell, Group Finance Director +44 (0)20 3077 6157 

Penrose Financial  +44(0)20 7786 4888 

Gay Collins Jesper Lofgren +44(0)7798 626282

Ashmore@penrose.co.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSVZLFFKFBFBBL
Date   Source Headline
16th Sep 20204:09 pmRNS2020 Annual Financial Report and Notice of AGM
11th Sep 20207:00 amRNSFinal Results
14th Jul 20207:00 amRNSTrading Statement
23rd Jun 20205:40 pmRNSDirector/PDMR Shareholding
19th Jun 20206:07 pmRNSDirector/PDMR Shareholding
19th Jun 20206:04 pmRNSHolding(s) in Company
27th Apr 20203:33 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20207:00 amRNSTrading Statement
6th Apr 20205:44 pmRNS2019 AGM voting result update statement
1st Apr 20209:51 amRNSDirector/PDMR Shareholding
16th Mar 20203:29 pmRNSHolding(s) in Company
13th Mar 20206:21 pmRNSDirector/PDMR Shareholding
7th Feb 20204:50 pmRNSDirector/PDMR Shareholding
7th Feb 20204:49 pmRNSHolding(s) in Company
6th Feb 20207:00 amRNSHalf-year Report
15th Jan 20207:00 amRNSTrading Statement
10th Dec 20199:16 amRNSDirector/PDMR Shareholding
9th Dec 20192:08 pmRNSDirector/PDMR Shareholding
11th Nov 201912:17 pmRNSDirector/PDMR Shareholding
21st Oct 201911:42 amRNSDirector Declaration
18th Oct 20193:32 pmRNSResult of AGM
16th Oct 20191:08 pmRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSTrading Statement
30th Sep 20195:38 pmRNSDirector/PDMR Shareholding
30th Sep 20195:33 pmRNSDirector/PDMR Shareholding
18th Sep 201912:04 pmRNSDirector/PDMR Shareholding
18th Sep 201912:01 pmRNSDirector/PDMR Shareholding
16th Sep 20192:07 pmRNS2019 Annual Report and Notice of AGM
6th Sep 20197:00 amRNSFinal Results
12th Jul 20197:00 amRNSTrading Statement
18th Apr 20195:08 pmRNSDirector/PDMR Shareholding
16th Apr 20197:00 amRNSTrading Statement
5th Apr 20198:57 amRNSDirector/PDMR Shareholding
3rd Apr 20194:37 pmRNSDirector/PDMR Shareholding
3rd Apr 20194:30 pmRNSHolding(s) in Company
14th Mar 20194:50 pmRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSHalf-year Report
15th Jan 20197:00 amRNSTrading Statement
10th Dec 20182:14 pmRNSDirector/PDMR Shareholding
19th Oct 20185:08 pmRNSResult of AGM
12th Oct 20187:00 amRNSTrading Statement
1st Oct 20188:13 amRNSTotal Voting Rights
18th Sep 20186:04 pmRNSDirector/PDMR Shareholding
18th Sep 20186:00 pmRNSDirector/PDMR Shareholding
13th Sep 20184:16 pmRNSHolding(s) in Company
13th Sep 20184:11 pmRNSNotice of AGM
11th Sep 20185:19 pmRNSHolding(s) in Company
11th Sep 20185:04 pmRNSTreasury Shares
7th Sep 20187:00 amRNSFinal Results
6th Sep 20181:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.